Nanologica
2,16
SEK
+2,37 %
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
+2,37%
+17,71%
+18,68%
-7,69%
-58,09%
-67,16%
-85,97%
-78,66%
-88,09%
Nanologica is a life science tools company that develops, manufactures and sells advanced consumables to pharmaceutical companies. Nanologica's silica-based products are specially designed for the purification of peptide drugs, such as insulin and GLP-1 analogs. Nanologica operates in a global niche market for medicines for the treatment of diabetes and obesity. Nanologica was founded in 2004 and has its headquarters in Södertälje.
Læs mereMarkedsværdi
190,85 mio. SEK
Aktieomsætning
103,59 t SEK
Omsætning
1,44 mio.
EBIT %
-4.858,33 %
P/E
-
Udbytteafkast, %
-
Finanskalender
7.2
2025
Årsrapport '24
17.4
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '25
ViserAlle indholdstyper
Nanologica Receives Order of NLAB Saga® Worth appx SEK 8.5 Million from Recurring Customer in China
Nanologica Receives Order on NLAB Saga® Valued at approx SEK 1,9 Million from Returning Customer in China
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools